Monoclonal Anti-Coxsackievirus A16 (strain G-10) VP0 Antibody, Human IgG1 (14E1) (MALS verified), Unconjugated

Artikelnummer: ABS-VP0-MY2108-100UG
Artikelname: Monoclonal Anti-Coxsackievirus A16 (strain G-10) VP0 Antibody, Human IgG1 (14E1) (MALS verified), Unconjugated
Artikelnummer: ABS-VP0-MY2108-100UG
Hersteller Artikelnummer: VP0-MY2108-100ug
Alternativnummer: ABS-VP0-MY2108-100UG
Hersteller: AcroBiosystems
Kategorie: Antikörper
Spezies Reaktivität: Mouse
Konjugation: Unconjugated
Cox A16 infection is very common in China, and the pathogenicity of Cox A16 is significantly different from enterovirus 71. Cox A16 can induce the production of a variety of micribonucleic acid, which affects the conduction of inflammatory signaling pathway, leading to the occurrence of pathological damage. Cox A16 capsid protein VP1, as an important target protein, interacts with host cell receptors to provide virion attachment to target host cells. - Antikörper
Tag: Human IgG1 | Human Kappa
Puffer: PBS, pH7.4
Reinheit: 0.95
Formulierung: Powder
Target-Kategorie: VP0 (Coxsackievirus A16)
VP0-MY2108-100ug